Antibody-coupled monolithic silica microtips for highthroughput molecular profiling of circulating exosomes

Scientific Reports

Volumn 4, Issue , 2014, Pages

  Ueda, Koji ^a,b   Ishikawa, Nobuhisa ^c   Tatsuguchi, Ayako ^b   Saichi, Naomi ^a,b   Fujii, Risa ^a,b   Nakagawa, Hidewaki ^b  

^a UNIVERSITY OF TOKYO   (Japan)

^b RIKEN   (Japan)

^c HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

IMMOBILIZED ANTIBODY; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; LRP1 PROTEIN, HUMAN; SILICON DIOXIDE; TUMOR MARKER;

ADENOCARCINOMA; ADULT; BLOOD; CHEMISTRY; EXOSOME; FEMALE; HUMAN; IMMUNOASSAY; IMMUNOLOGY; ISOLATION AND PURIFICATION; LUNG NEOPLASMS; MALE; METABOLISM; RECEIVER OPERATING CHARACTERISTIC; TANDEM MASS SPECTROMETRY;

ADENOCARCINOMA; ADULT; ANTIBODIES, IMMOBILIZED; EXOSOMES; FEMALE; HUMANS; IMMUNOASSAY; LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN-1; LUNG NEOPLASMS; MALE; ROC CURVE; SILICON DIOXIDE; TANDEM MASS SPECTROMETRY; TUMOR MARKERS, BIOLOGICAL;

EID: 84906818368     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep06232     Document Type: Article

References (29)

1. Lehtio, J. & De Petris, L. Lung cancer proteomics, clinical and technological considerations. J Proteomics 73, 1851-1863 (2010).
2. Luga, V. et al. Exosomes mediate stromal mobilization of autocrine Wnt-PCP signaling in breast cancer cell migration. Cell 151, 1542-1556 (2012).
3. Peinado, H. et al. Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET. Nature medicine 18, 883-891 (2012).
4. Kosaka, N. et al. Neutral sphingomyelinase 2 (nSMase2)-dependent exosomal transfer of angiogenic microRNAs regulate cancer cell metastasis. J Biol Chem 288, 10849-10859 (2013).
5. Grapp, M. et al. Choroid plexus transcytosis and exosome shuttling deliver folate into brain parenchyma. Nature communications 4, 2123 (2013).
6. El-Andaloussi, S. et al. Exosome-mediated delivery of siRNA in vitro and in vivo. Nat Protoc 7, 2112-2126 (2012).
7. Sandoval, M. et al. The glycolytic enzyme aldolase C is up-regulated in rat forebrain microsomes and in the cerebrospinal fluid after repetitive fluoxetine treatment. Brain research 1520, 1-14 (2013).
8. Tanaka, Y. et al. Clinical impact of serum exosomal microRNA-21 as a clinical biomarker in human esophageal squamous cell carcinoma. Cancer 119, 1159-1167 (2013).
9. Khan, S. et al. Plasma-derived exosomal survivin, a plausible biomarker for early detection of prostate cancer. PLoS One 7, e46737 (2012).
10. Lasser, C. Identification and analysis of circulating exosomal microRNA in human body fluids. Methods in molecular biology 1024, 109-128 (2013).
11. Witwer, K. W. et al. Standardization of sample collection, isolation and analysis methods in extracellular vesicle research. Journal of extracellular vesicles 2, 20360 (2013).
12. Keller, S., Sanderson, M. P., Stoeck, A. & Altevogt, P. Exosomes: from biogenesis and secretion to biological function. Immunology letters 107, 102-108 (2006).
13. Ford, G., Xu, Z., Gates, A., Jiang, J. & Ford, B. D. Expression Analysis Systematic Explorer (EASE) analysis reveals differential gene expression in permanent and transient focal stroke rat models. Brain research 1071, 226-236 (2006).
14. Tan, P. K. et al. Evaluation of gene expression measurements from commercial microarray platforms. Nucleic acids research 31, 5676-5684 (2003).
15. Taylor, D. D., Zacharias, W. & Gercel-Taylor, C. Exosome isolation for proteomic analyses and RNA profiling. Methods in molecular biology 728, 235-246 (2011).
16. Sixt, S. U. & Dahlmann, B. Extracellular, circulating proteasomes and ubiquitin-incidence and relevance. Biochimica et biophysica acta 1782, 817-823 (2008).
17. Egerer, K. et al. Circulating proteasomes are markers of cell damage and immunologic activity in autoimmune diseases. The Journal of rheumatology 29, 2045-2052 (2002).
18. Kedersha, N. L., Heuser, J. E., Chugani, D. C. & Rome, L. H. Vaults. III. Vault ribonucleoprotein particles open into flower-like structures with octagonal symmetry. The Journal of cell biology 112, 225-235 (1991).
19. Huang, C. et al. MRP-1/CD9 and KAI1/CD82 expression in normal and various cancer tissues. Int J Oncol 11, 1045-1051 (1997).
20. Miyake, M. et al. Motility related protein 1 (MRP-1/CD9) expression: inverse correlation with metastases in breast cancer. Cancer Res 55, 4127-4131 (1995).
21. Sauer, G. et al. Progression of cervical carcinomas is associated with downregulation of CD9 but strong local re-expression at sites of transendothelial invasion. Clin Cancer Res 9, 6426-6431 (2003).
22. Strickland, D. K.,Gonias, S. L.& Argraves, W. S. Diverse roles for the LDL receptor family. Trends in endocrinology and metabolism: TEM 13, 66-74 (2002).
23. Weaver, A. M., McCabe, M., Kim, I., Allietta, M. M. & Gonias, S. L. Epidermal growth factor and platelet-derived growth factor-BB induce a stable increase in the activity of low density lipoprotein receptor-related protein in vascular smooth muscle cells by altering receptor distribution and recycling. J Biol Chem 271, 24894-24900 (1996).
24. Yoon, C. et al. Low-density Lipoprotein Receptor-related Protein 1 (LRP1)-dependent Cell Signaling Promotes Axonal Regeneration. J Biol Chem 288, 26557-26568 (2013).
25. Stiles, T. L. et al. LDL receptor-related protein-1 is a sialic-acid-independent receptor for myelin-associated glycoprotein that functions in neurite outgrowth inhibition by MAG and CNS myelin. Journal of cell science 126, 209-220 (2013).
26. Meng, H. et al. Stromal LRP1 in lung adenocarcinoma predicts clinical outcome. Clin Cancer Res 17, 2426-2433 (2011).
27. Vassiliou,G., Benoist, F., Lau, P., Kavaslar, G. N.& McPherson, R. The low density lipoprotein receptor-related protein contributes to selective uptake of high density lipoprotein cholesteryl esters by SW872 liposarcoma cells and primary human adipocytes. J Biol Chem 276, 48823-48830 (2001).
28. Wang, W. et al. HM1.24 (CD317) is a novel target against lung cancer for immunotherapy using anti-HM1.24 antibody. Cancer immunology, immunotherapy : CII 58, 967-976 (2009).
29. Wang, W. et al. Chimeric and humanized anti-HM1.24 antibodies mediate antibody-dependent cellular cytotoxicity against lung cancer cells. Lung cancer 63, 23-31 (2009).